Shenzhen YHLO Biotech Co., Ltd. (688575.SS) SHH

Currency In CNY

AD

Valuation

Market Cap8.53B
Enterprise Value8.99B
P/E Ratio128.57
PEG Ratio-1.54
Price/Sales Ratio2.87
Price/Book Ratio1.9
Enterprise/Revenue3.08
Enterprise/EBITDA17.51

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.02
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue1.81B
Revenue/Share3.13
Gross Profit1.81B
EBITDA481.96M
Net Income23.34M
Diluted EPS0.04

Balance Sheet

Total Cash715.73M
Total Cash/Share1.25
Total Debt963.95M
Total Debt/Equity0.36
Current Ratio2.19
Book Value Per Share4.73

Price History

52-Week Change-39.27
52-Week High17
52-Week Low8.34
Moving Average 50 Days10.58
Moving Average 200 Days13.59

Statistics

Average Volume6.86M
Shares Outstanding571.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.02
Trailing Annual Dividend Yield0.23
Payout Ratio4.28
Last Split Factor7:5
Last Split DateJune 02, 2022
AD